| Product Code: ETC7653086 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Heart Failure Diagnostics/Therapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Heart Failure Diagnostics/Therapeutics Market - Industry Life Cycle |
3.4 Israel Heart Failure Diagnostics/Therapeutics Market - Porter's Five Forces |
3.5 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume Share, By Tests, 2021 & 2031F |
4 Israel Heart Failure Diagnostics/Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of heart failure in Israel |
4.2.2 Technological advancements in heart failure diagnostics and therapeutics |
4.2.3 Growing healthcare expenditure and focus on cardiovascular diseases |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of diagnostics and therapeutics |
4.3.2 High cost associated with heart failure treatments |
4.3.3 Limited awareness and access to advanced diagnostics and therapeutics in certain regions of Israel |
5 Israel Heart Failure Diagnostics/Therapeutics Market Trends |
6 Israel Heart Failure Diagnostics/Therapeutics Market, By Types |
6.1 Israel Heart Failure Diagnostics/Therapeutics Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Cardiac Resynchronization Therapy, 2021- 2031F |
6.1.4 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Ventricular Assist Devices, 2021- 2031F |
6.1.5 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Counterpulsation Implants, 2021- 2031F |
6.1.6 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Heart Failure Surgery, 2021- 2031F |
6.1.7 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Fluid Reduction (Renal Impairment), 2021- 2031F |
6.1.8 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Neurostimulation, 2021- 2031F |
6.1.9 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Central Sleep Apnea, 2021- 2031F |
6.1.10 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Central Sleep Apnea, 2021- 2031F |
6.2 Israel Heart Failure Diagnostics/Therapeutics Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By ECG Systems, 2021- 2031F |
6.2.3 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Holter Monitors, 2021- 2031F |
6.2.4 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Event Monitors, 2021- 2031F |
6.2.5 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Implantable Loop Recorders, 2021- 2031F |
6.3 Israel Heart Failure Diagnostics/Therapeutics Market, By Tests |
6.3.1 Overview and Analysis |
6.3.2 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.3.3 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Chest X Ray, 2021- 2031F |
6.3.4 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Electrocardiogram, 2021- 2031F |
6.3.5 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Echocardiogram, 2021- 2031F |
6.3.6 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Stress Test, 2021- 2031F |
6.3.7 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Cardiac Computerized Tomography (CT) Scan or Magnetic Resonance Imaging, 2021- 2031F |
6.3.8 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Myocardial Biopsy, 2021- 2031F |
6.3.9 Israel Heart Failure Diagnostics/Therapeutics Market Revenues & Volume, By Myocardial Biopsy, 2021- 2031F |
7 Israel Heart Failure Diagnostics/Therapeutics Market Import-Export Trade Statistics |
7.1 Israel Heart Failure Diagnostics/Therapeutics Market Export to Major Countries |
7.2 Israel Heart Failure Diagnostics/Therapeutics Market Imports from Major Countries |
8 Israel Heart Failure Diagnostics/Therapeutics Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rate of new diagnostic technologies |
8.3 Number of healthcare facilities offering specialized heart failure treatments |
8.4 Research and development investment in innovative diagnostics and therapeutics |
8.5 Patient satisfaction scores with heart failure treatment options |
9 Israel Heart Failure Diagnostics/Therapeutics Market - Opportunity Assessment |
9.1 Israel Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 Israel Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Israel Heart Failure Diagnostics/Therapeutics Market Opportunity Assessment, By Tests, 2021 & 2031F |
10 Israel Heart Failure Diagnostics/Therapeutics Market - Competitive Landscape |
10.1 Israel Heart Failure Diagnostics/Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel Heart Failure Diagnostics/Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here